Otezla is a medication used to treat moderate to severe plaque psoriasis and active psoriatic arthritis. Psoriasis is a skin condition characterized by red, scaly patches on the skin while psoriatic arthritis is a form of arthritis that affects some people who have psoriasis. Otezla contains apremilast, an oral PDE-4 inhibitor that works by lowering the levels of a certain enzyme in the body that contributes to inflammation. By reducing inflammation, Otezla can improve the symptoms associated with psoriasis and psoriatic arthritis.
Common side effects of Otezla may include diarrhea, nausea, and headache. It is important to discuss any potential side effects with a healthcare provider before starting treatment. Otezla is only available through a prescription and the dosage will vary depending on the individual's specific condition and medical history.
Financial support is available for individuals who need assistance affording Otezla. It is important to consult with a healthcare provider to determine if Otezla is the right treatment option for a particular individual's condition and to discuss any potential risks or concerns.
Otezla is a pharmaceutical company that specializes in the treatment of psoriasis, a chronic skin condition characterized by itchy, scaly patches on the skin. The company is committed to improving the...